HomeEKTA-B • STO
add
Elekta AB (publ)
Previous close
kr 59.05
Day range
kr 58.75 - kr 59.80
Year range
kr 57.95 - kr 88.85
Market cap
21.99B SEK
Avg Volume
1.20M
P/E ratio
21.98
Dividend yield
4.02%
Primary exchange
STO
Financials
Income Statement
Revenue
Net income
| (SEK) | Jan 2025info | Y/Y change |
|---|---|---|
Revenue | 4.70B | 3.48% |
Operating expense | 1.22B | 12.02% |
Net income | 341.00M | 11.80% |
Net profit margin | 7.26 | 8.04% |
Earnings per share | 0.94 | 6.82% |
EBITDA | 678.00M | -8.50% |
Effective tax rate | 22.04% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Jan 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.58B | 52.34% |
Total assets | 32.95B | 7.23% |
Total liabilities | 22.12B | 8.03% |
Total equity | 10.83B | — |
Shares outstanding | 382.08M | — |
Price to book | 2.09 | — |
Return on assets | 3.96% | — |
Return on capital | 6.58% | — |
Cash Flow
Net change in cash
| (SEK) | Jan 2025info | Y/Y change |
|---|---|---|
Net income | 341.00M | 11.80% |
Cash from operations | 1.10B | 2.15% |
Cash from investing | -371.00M | 27.82% |
Cash from financing | -511.00M | -1,803.33% |
Net change in cash | 231.00M | -52.17% |
Free cash flow | 733.00M | 131.32% |
About
Elekta is a global Swedish company that develops and produces radiation therapy and radiosurgery-related equipment and clinical management for the treatment of cancer and brain disorders. Elekta has a global presence in more than 120 countries, with over 40 offices around the world and about 4,700 employees. Wikipedia
Founded
1972
Website
Employees
4,541
